- Home
- TERN vs HOMB Comparison
TERN vs HOMB Comparison
Compare TERN & HOMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TERN | HOMB |
|---|---|---|
| Founded | 2017 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.3B |
| IPO Year | 2021 | 2006 |
Fundamental Metrics
Financial Performance| Metric | TERN | HOMB |
|---|---|---|
| Price | $52.67 | $28.16 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 5 |
| Target Price | ★ $46.72 | $32.40 |
| AVG Volume (30 Days) | ★ 9.0M | 1.2M |
| Earning Date | 05-07-2026 | 04-15-2026 |
| Dividend Yield | N/A | ★ 3.06% |
| EPS Growth | 8.04 | ★ 19.90 |
| EPS | N/A | ★ 2.41 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $10.99 |
| Revenue Next Year | N/A | $5.14 |
| P/E Ratio | ★ N/A | $11.38 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.04 | $24.52 |
| 52 Week High | $53.19 | $30.83 |
Technical Indicators
Market Signals| Indicator | TERN | HOMB |
|---|---|---|
| Relative Strength Index (RSI) | 73.83 | 64.15 |
| Support Level | $38.99 | $28.10 |
| Resistance Level | $53.19 | $28.74 |
| Average True Range (ATR) | 0.90 | 0.49 |
| MACD | -0.15 | 0.25 |
| Stochastic Oscillator | 91.61 | 90.02 |
Price Performance
Historical ComparisonAbout TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
About HOMB Home BancShares Inc.
Home BancShares Inc is a bank holding company that operates through its wholly owned community bank subsidiary, Centennial Bank. The bank provides a broad range of commercial and retail banking, as well as related financial services, to a diverse customer base. Its customer base includes businesses, real estate developers and investors, individuals, and municipalities. The company's loan portfolio, while diversified, is typically between half and two thirds in commercial real estate loans. The company's plan emphasizes growth, both through strategic acquisitions and organically within its existing markets. The company has one reportable segment: The Banking Segment.